NP49425 Generic and Biosimilar Transition Medicines
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 32 month
- Value
- £188K-£64M
- Sector
- HEALTH
- Published
- 30 Mar 2026
- Delivery
- 01 Feb 2026 to 30 Sep 2028 (est.)
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
2 suppliers
- Brown & Burk West London
- Lupin Healthcare Slough
Description
Supply of generic and biosimilar transition medicines to NHS Scotland. The Authority has awarded the Framework Agreement across multiple Lots (please review Award Notice for information).
Ammendments to Previous Notice
2. Contract value
GBP 64,103,740
Award Detail
| 1 | Brown & Burk (West London)
|
| 2 | Lupin Healthcare (Slough)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
No changes; clarification of Framework Agreement initial duration (thirty-two (32) months) and extension duration (sixteen (16) months) only. Individual Lot durations vary and information is available on request.
Other Information
The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:827046)
Reference
- FTS 029168-2026